Project Fusion
Spine, Extremities, Trauma, Oncology (Evidence Generation)
Research ProgramActive
Key Facts
Indication
Spine, Extremities, Trauma, Oncology (Evidence Generation)
Phase
Research Program
Status
Active
Company
About Kuros Biosciences
Kuros Biosciences is a commercial-stage orthobiologics company with a mission to deliver innovative biologic technologies for safer, faster, and more predictable bone healing. The company has achieved a global commercial footprint in over 20 markets and is building a robust Level I clinical evidence package through its Project Fusion research program. Its strategy centers on leveraging its proprietary NeedleGrip™ surface technology to address the significant clinical and economic burden of bone non-unions, aiming to become a leader in the $5B+ bone graft substitute market.
View full company profile